Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | CHUK | O15111 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | NOS2 | P35228 | 1/20 | 0.41 |
| ▸ | DCK | P27707 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066071 | 0.83 | RAB9A (0.56) | ADORA2AADORA1DPP4MEN1KMT2A | |
| SCHEMBL4050723 | 0.80 | ADORA2A (0.48) | ADORA2AADORA1DPP4ADORA2BMTOR | |
| SCHEMBL26806827 | 0.78 | NOS3 (0.50) | ADORA2AADORA1DPP4ADORA2BKDM4E | |
| SCHEMBL25511533 | 0.78 | ADORA2A (0.49) | ADORA2AADORA1DPP4ADORA2BKDM4E | |
| SCHEMBL25224282 | 0.77 | NOS3 (0.45) | ADORA2AADORA1ADORA2BKDM4EMEN1 | |
| SCHEMBL4504821 | 0.77 | MTOR (0.57) | ADORA2AADORA1ADORA2BMTORKDM4E | |
| SCHEMBL28231629 | 0.76 | TP53 (0.43) | ADORA2AADORA1DPP4MEN1MAPT | |
| SCHEMBL28663052 | 0.76 | ADORA2A (0.54) | ADORA2AADORA1ADORA2BMTORMEN1 | |
| SCHEMBL1259535 | 0.76 | ADORA1 (0.49) | ADORA2AADORA1DPP4ADORA2BKDM4E | |
| SCHEMBL18748036 | 0.76 | ADORA2A (0.57) | ADORA2AADORA1DPP4ADORA2BKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151025-A1 | SUBSTITUTED THIAZOLOPYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AG (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151025-A1 | SUBSTITUTED THIAZOLOPYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AG (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151025-A1 | SUBSTITUTED THIAZOLOPYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AG (DE) | 2023-05-18 | — | — | US | disclosed |
| CN-115698021-A | Substituted thiazolopyridines, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-02-03 | — | — | CN | disclosed |
| WO-2009136663-A1 | FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151025-A1 | SUBSTITUTED THIAZOLOPYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | TST, DDT, GMDS | ADORA2A 2394/4885ADORA1 1588/4885DPP4 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.